Litigation Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)
✉ Email this page to a colleague
Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-04-03 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:0145 | Assigned To | Leonard Philip Stark |
| Jury Demand | Referred To | ||
| Patents | 6,992,218; 9,399,012; 9,610,265 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Mallinckrodt IP v. B. Braun Medical Inc.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Mallinckrodt IP v. B. Braun Medical Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-06-05 | 167 | Opinion - Memorandum Opinion | to a Paragraph IV certification to U.S . Patent No. 6,992,218 from Defendant B. Braun Medical Inc. (&… 012 patent and U.S. Patent No. 9,610,265 (collectively with the ' 012 and ' 218 patents, the …alleging infringement of the ' 218 patent and U.S . Patent No. 9,399,012. On May 31, 2017, in response…the "asserted patents"). The ' 218 patent is directed to the manufacture of aqueous formulations…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
